Ketamine Therapy: A New Hope for Depression
Consider a clinical environment in which the quality of care in treating depression has been stagnant at almost 40 cents. The trial-and-error clinical experience of antidepressants, be it selective serotonin reuptake (SSRI) or serotonin-norepinephrine reuptake inhibitors (SNRIs), offers little more
